trending Market Intelligence /marketintelligence/en/news-insights/trending/UfUixYMIhRn6cNI5dVOFPA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Ophthotech undertaking strategic review of business

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Ophthotech undertaking strategic review of business

Ophthotech Corp. said it was undertaking a strategic review of the business.

The company engaged Leerink Partners LLC as its financial adviser to assist in evaluating the company's strategic alternatives. "[T]he principal focus of this plan ... is to actively explore obtaining rights to additional products, product candidates and technologies to treat ophthalmic diseases, particularly those of the back of the eye."

As part of those efforts, Ophthotech appointed Glenn Sblendorio as its new president and Keith Westby as its new senior vice president and COO.

Sblendorio will continue to serve as the company's CFO. Westby was previously Ophthotech's senior vice president of development operations.